Physician profile
Lee E Eslava
NPI 1639125602
$886.48
in general payments reported to CMS, 2019-2025
17 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $12.72 · 2021: $72.10 · 2022: $99.26 · 2023: $241 · 2024: $160 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $260.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Ceribell, INC. | $188.34 | 2023 | Ceribell Rapid Response Eeg |
| Abbvie INC. | $71.12 | 2021-2022 | |
| Allergan, INC. | $55.58 | 2019-2020 | |
| Lilly USA, LLC | $49.20 | 2022-2024 | Zepbound, Jardiance, Mounjaro |
| Janssen Pharmaceuticals, INC | $44.95 | 2019 | |
| Dexcom, INC. | $31.20 | 2023-2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.11 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.84 | 2021 | |
| Glaxosmithkline, LLC. | $22.39 | 2023 | Shingrix, Arexvy |
| Exact Sciences Corporation | $21.32 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $20.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.14 | 2024 | Trintellix |
| Davol INC. | $14.44 | 2024 | Channel Drain |
| Sanofi Pasteur INC. | $14.23 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.82 | 2019 | |
| Daiichi Sankyo INC. | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Eslava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.